Skip to main content
. 2018 Nov 20;2018(11):MR000005. doi: 10.1002/14651858.MR000005.pub4

Stranges 2015.

Methods Identification of subsequent full‐length publications
  • Searched electronic database

    • MEDLINE, SCOPUS, and International Pharmaceutical Abstracts for a '5 year interval'

    • Search completed by the investigator

    • Searched by all authors, and keywords

    • Matching criteria not reported

Data
  • Included 655 abstracts presented at the 2003, 2005, and 2007 Great Lakes Pharmacy Residency Conference meetings

  • Included all abstracts

Comparisons
  • Proportion of abstracts published, overall and by meeting

  • Mean time to publication

  • Clinical research versus basic science research versus survey versus service development

  • RCT design versus observational design versus other interventional design

  • Academic center versus veterans affairs institution versus community/retail institution versus hospital versus other institution affiliation

  • Prospective versus retrospective design

  • Results presented in abstract versus not

  • Intervention on drugs versus humans versus other topics

Outcomes
  • 76 of 655 abstracts published

  • 22/171 abstracts presented at the 2003 meeting, 27/221 at the 2005 meeting, and 27/273 at the 2007 meeting published

  • Proportion of abstracts published by time

    • Mean time to publication = 24.5 months (SD = 14.3)

  • Factors related to proportion of abstracts published included

    • 58/546 abstracts describing clinical research versus 2/8 abstracts describing basic science research versus 13/39 abstracts describing surveys versus 3/72 abstracts describing service development published

    • 1/20 abstracts describing RCT versus 63/573 abstracts describing observational design versus 13/72 abstracts describing other interventional design published

    • 49/287 abstracts originating in an academic center versus 6/101 abstracts originating from a veterans affairs institution versus 3/24 abstracts originating from community/retail institutions versus 18/248 abstracts originating with hospitals versus 0/5 abstracts originating from other institutions published

    • 16/101 abstracts describing prospective design versus 60/564 abstracts describing retrospective design published

    • 18/111 abstracts with results presented in abstract versus 58/554 abstracts with no results presented in abstract published

    • 26/304 abstracts describing drug intervention versus 28/206 abstracts describing 'human' intervention versus 22/155 abstracts describing other intervention published

Notes
  • Pharmacology

  • Funded by the National Center for Advancing Translational Sciences

Risk of bias
Item Authors' judgement Description
Sampling method? Yes Included all abstracts.
Search for publications? Yes Searched 3 databases.
Follow‐up time? Yes All meetings had 60 months follow‐up.
Matching? Unclear Matching criteria not reported.
Adjustment for confounding? Yes Examined association of meeting year, type of science, study design, academic affiliation, prospective status, presentation of results, and type clinical study with publication using multivariable logistic regression.